U.S. federal trademark · Serial No. 97776646
Research and development in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, NAD deficiency, aging, and aging-related diseases, disorders, and conditions for humans and animals
Pharmaceutical preparations for humans and animals for purposes of increasing intracellular NAD+ to prevent aging conditions and disorders; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations in the nature of an oral composition of NAD+ for treating and managing NAD deficiency and supplementing coenzyme depletion; Therapeutic pharmaceutical agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.